Advertisement

Topics

NICE backs new therapy for Fabry disease

06:10 EDT 19 Oct 2016 | PharmaTimes

Cost regulators for the NHS in England and Wales are backing use of a new therapy to treat the rare genetic disorder Fabry disease with a price tag of £210,000 per patient per year (excluding VAT and any discounts).

Original Article: NICE backs new therapy for Fabry disease

NEXT ARTICLE

More From BioPortfolio on "NICE backs new therapy for Fabry disease"

Quick Search
Advertisement